Methandriol propionate
Appearance
![]() | |
Clinical data | |
---|---|
Trade names | Metilbisexovis |
Other names | Methylandrostenediol propionate; Methylandrostenediol 3β-propionate; 17α-Methylandrost-5-ene-3β,17β-diol 3β-propionate |
Routes of administration | Intramuscular injection |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H36O3 |
Molar mass | 360.538 g·mol−1 |
3D model (JSmol) | |
| |
|
Methandriol propionate (brand name Metilbisexovis), or methylandrostenediol propionate, also known as 17α-methylandrost-5-ene-3β,17β-diol 3β-propionate, is a synthetic, injected anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of 5-androstenediol that is or was marketed by Vister in Italy.[1][2][3] It is an androgen ester – specifically, the C3,17β propionate ester of methandriol (17α-methyl-5-androstenediol) – and acts as a prodrug of methandriol in the body.[1] Methandriol propionate is administered by intramuscular injection and, relative to methandriol, has an extended duration via this route due to a depot effect afforded by its ester.[citation needed]
See also
[edit]References
[edit]- ^ a b Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 663–. ISBN 978-3-88763-075-1.
- ^ Charles D. Kochakian (6 December 2012). Anabolic-Androgenic Steroids. Springer Science & Business Media. pp. 635–. ISBN 978-3-642-66353-6.
- ^ DE RUGGIERI P, DE GIUSEPPE L (1953). "[Determination and identification of hormonal steroids in pharmaceutical preparations. IV. Solutions of methylandrostenediol propionate and androstenedion dipropionate in oil]". Farmaco Sci. 8 (12): 703–5. PMID 13142030.